2 completed, 1 recruiting, 1 unknown, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 2, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow agalsidase alfa: new trials by email Literature Review of agalsidase alfa trials Research Report on agalsidase alfa
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Replagal in Children and Adults With Fabry Disease in India Replagal - Fabry Disease | Phase 4 | Recruiting | Shire | 5 | 2022-11-01 | 2026-09-03 |
| To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry Disease agalsidase beta (GZ419828), agalsidase alfa - Fabry Disease | Phase 4 | Withdrawn | Sanofi | 2020-09-01 | 2023-04-07 | |
| Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease recombinant alpha-galactosidase A - Fabry Disease | Phase 4 | Unknown | Assistance Publique - Hôpitaux de Paris | 34 | 2005-06-01 | 2007-06-18 |
| Replagal Enzyme Replacement Therapy for Adults With Fabry Disease Replagal (Agalsidase Alfa), Replagal - Fabry Disease | Phase 4 | Completed | National Institute of Neurological Disorders and Stroke (NINDS) | 25 | 2004-11-01 | 2008-03-04 |
| Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients. Enzyme replacement - Fabry Disease | Phase 4 | Completed | Copenhagen University Hospital, Rigshospitalet | 39 | 2001-09-01 | 2014-10-28 |
Fabry Disease (5) · Cardiomyopathies (1) · Stroke (1)
Assistance Publique - Hôpitaux de Paris (1) · Copenhagen University Hospital, Rigshospitalet (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · Sanofi (1) · Shire (1)
Denmark (1) · France (1) · India (1) · United States (1)
Ulla Feldt-Rasmussen, MD, DMSc (1)
2019 (1)